MTCM
NAMSW icon

Mint Tower Capital Management’s NewAmsterdam Pharma Warrant NAMSW Stock Holding History

Mint Tower Capital Management’s Portfolio NAMSW Stock Details NAMSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-6,533
Closed -$12K – 292
2023
Q1 		$12K Hold
6,533
– – ﹤0.01% 219
2022
Q4 		$6K Buy
+6,533
New +$5.38K ﹤0.01% 323

Other funds holding NAMSW

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Mint Tower Capital Management's NAMSW Position: Q2 2023 in Review

Mint Tower Capital Management sold out of NewAmsterdam Pharma Warrant (NAMSW) in Q2 2023, closing a stake of 6,533 shares — an estimated $12K sold.

Mint Tower Capital Management first reported a position in NAMSW in Q4 2022 and held it in 2 quarters. The position peaked at $12K in Q1 2023. 18 funds tracked by Wall St. Rank hold NAMSW as of Q2 2023.

  • Mint Tower Capital Management reported no remaining NewAmsterdam Pharma Warrant position as of Q2 2023 after selling out during the quarter.
  • Mint Tower Capital Management sold 6,533 NewAmsterdam Pharma Warrant shares in Q2 2023, an estimated $12K.
  • Mint Tower Capital Management first reported a position in NewAmsterdam Pharma Warrant in Q4 2022 and held it in 2 quarters.
  • Mint Tower Capital Management's NewAmsterdam Pharma Warrant position peaked at $12K in Q1 2023.
  • 18 funds tracked by Wall St. Rank held NewAmsterdam Pharma Warrant as of Q2 2023.

Based on Mint Tower Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.